Expression Patterns of Glucose Transporter-1 Gene and Thyroid Specific Genes in Human Papillary Thyroid Carcinoma

Sungeun Kim, June Key Chung, Hae Sook Min, Joo Hyun Kang, Do Joon Park, Jae Min Jeong, Dong Soo Lee, Sung Hwae Park, Bo Youn Cho, Sinae Lee, Myung Chul Lee

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)


Purpose: The expression of glucose transporter-1 (Glut-1) gene and those of major thyroid-specific genes were examined in papillary carcinoma tissues, and the expressions of these genes were compared with cancer differentiation grades. Materials and Methods: Twenty-four human papillary carcinoma tissues were included in this study. The expressions of Glut-1- and thyroid-specific genes [sodium/iodide symporter (NIS), thyroid peroxidase, thyroglobulin, TSH receptor and pendrin] were analyzed by RT-PCR. Expression levels were expressed as ratios versus the expression of beta-actin. Pathologic differentiation of papillary carcinoma was classified into a relatively well-differentiated group (n = 13) and relatively less differentiated group (n = 11). Results: Glut-1 gene expression was significantly higher in the less differentiated group (0.66 ± 0.04) than in the well-differentiated group (0.59 ± 0.07). The expression levels of the NIS, PD and TG genes were significantly higher in the well-differentiated group (NIS: 0.67 ± 0.20, PD: 0.65 ± 0.21, TG: 0.74 ± 0.16) than in the less differentiated group (NIS: 0.36 ± 0.05, PD: 0.49 ± 0.08, TG: 0.60 ± 0.11), respectively. A significant negative correlation was found between Glut-1 and NIS expression, and positive correlations were found between NIS and TG, and between NIS and PD. Conclusion: The NIS, PD and TG genes were highly expressed in well-differentiated thyroid carcinomas, whereas the Glut-1 gene was highly expressed in less differentiated thyroid carcinomas. These findings provide a molecular rationale for the management of papillary carcinoma, especially in the selection of FDG PET or radioiodine whole-body scan and I-131-based therapy.

Original languageEnglish
Pages (from-to)91-97
Number of pages7
JournalNuclear Medicine and Molecular Imaging
Issue number2
Publication statusPublished - 2014 Jun
Externally publishedYes

Bibliographical note

Funding Information:
This study was supported by the Seoul National University Hospital Research Fund (grant no. 03-2004-013-0) and a grant from the Korean Health Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (A070001), and a grant from Korea University (grant no. K1132631 and K0714991).


  • Glucose transporter-1
  • Papillary thyroid cancer
  • Pendrin
  • Sodium/iodide symporter
  • TSH receptor
  • Thyroglobulin
  • Thyroid peroxidase

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Expression Patterns of Glucose Transporter-1 Gene and Thyroid Specific Genes in Human Papillary Thyroid Carcinoma'. Together they form a unique fingerprint.

Cite this